XML 27 R16.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2019
Stock-Based Compensation  
Stock-Based Compensation

Note 9. Stock-Based Compensation

 

We account for stock-based compensation in accordance with the provisions of ASC Topic 718, Compensation-Stock Compensation (“ASC 718”), which established accounting for stock-based awards exchanged for employee services. Stock-based compensation cost is measured at each grant date, based on the fair value of the award, and is recognized as expense over the employee’s requisite service period of the award. All of our stock compensation is accounted for as an equity instrument.

 

The following table summarizes compensation costs related to our stock-based awards (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

June 30, 

 

June 30, 

 

 

    

2019

    

2018

    

2019

    

2018

 

Cost of revenue

 

$

30

 

$

21

 

$

61

 

$

42

 

Selling, general and administrative

 

 

426

 

 

368

 

 

863

 

 

737

 

Research and development

 

 

112

 

 

75

 

 

202

 

 

152

 

Total stock-based compensation

 

 

568

 

 

464

 

 

1,126

 

 

931

 

Tax effect on stock-based compensation

 

 

 —

 

 

 —

 

 

 —

 

 

 —

 

Net effect on net income

 

$

568

 

$

464

 

$

1,126

 

$

931

 

 

As of June 30, 2019, the unamortized compensation costs related to unvested stock options granted to employees under our stock option plan was approximately $1.2 million, net of estimated forfeitures of $136,000. These costs will be amortized on a straight-line basis over a weighted-average period of approximately 2.1 years and will be adjusted for subsequent changes in estimated forfeitures. We did not capitalize any stock-based compensation to inventory as of June 30, 2019 and December 31, 2018 due to the immateriality of the amount.

 

We estimate the fair value of stock options using the Black-Scholes valuation model, consistent with the provisions of ASC 718. There were no  options granted in the three and six months ended June 30, 2019 and 2018.  

 

 

The following table summarizes the stock option transactions during the six months ended June 30, 2019 (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

    

 

    

 

 

    

average

    

 

 

 

 

 

 

 

Weighted-

 

Remaining

 

 

 

 

 

 

Number of

 

average

 

Contractual

 

Aggregate

 

 

 

Options

 

Exercise

 

Life

 

Intrinsic

 

Stock Options

    

Outstanding

    

Price

    

(in years)

    

Value

 

Balance as of January 1, 2019

 

2,654

 

$

4.09

 

6.28

 

$

2,720

 

Granted

 

 —

 

 

 —

 

 

 

 

 

 

Exercised

 

(98)

 

 

2.38

 

 

 

 

 

 

Canceled and expired

 

(13)

 

 

4.25

 

 

 

 

 

 

Balance as of June 30, 2019

 

2,543

 

$

4.15

 

5.78

 

$

2,022

 

Options vested as of June 30, 2019 and unvested options expected to vest, net of forfeitures

 

2,525

 

$

4.14

 

5.76

 

$

2,022

 

Options exercisable as of June 30, 2019

 

1,949

 

$

3.70

 

5.05

 

$

1,875

 

 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing price of $3.96 on June 30, 2019, which would have been received by the option holder had all option holders exercised their options on that date.

 

Restricted stock awards

 

A summary of activity related to restricted stock awards for the six months ended June 30, 2019 is presented below (in thousands, except per share data):

 

 

 

 

 

 

 

 

    

 

    

Weighted-Average

 

 

 

 

 

Grant Date

 

Stock Awards

    

Shares

    

Fair Value

 

Non-vested as of January 1, 2019

 

633

 

$

6.85

 

Granted

 

142

 

$

5.14

 

Vested

 

(57)

 

$

8.54

 

Forfeited

 

(19)

 

$

7.16

 

Non-vested as of June 30, 2019

 

699

 

$

6.35

 

 

As of June 30, 2019, the unamortized compensation costs related to unvested restricted stock awards was approximately $3.8 million, which is to be amortized on a straight-line basis over a weighted-average period of approximately 1.53 years.